Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on-treatment platelet reactivity and diabetes mellitus status-Reference-Cited by-同舟云学术

Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on-treatment platelet reactivity and diabetes mellitus status

Published:2012-04-17 Issue:1 Volume:81 Page:42-49
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Capranzano Piera,Ferreiro Jose Luis,Ueno Masafumi,Capodanno Davide,Dharmashankar Kodlipet,Darlington Andrew,Desai Bhaloo,Tello-Montoliu Antonio,Rollini Fabiana,Angiolillo Dominick J.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.24416/fullpdf

Reference34 articles.

1. Variability in individual responsiveness to clopidogrel: Clinical implications, management, and future perspectives;Angiolillo;J Am Coll Cardiol,2007

2. Clopidogrel response variability: Current status and future directions;Ferreiro;Thromb Haemost,2009

3. Working Group on High On-Treatment Platelet Reactivity. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate;Bonello;J Am Coll Cardiol,2010

4. Optimizing platelet inhibition in clopidogrel poor metabolizers therapeutic options and practical considerations;Angiolillo;JACC Cardiovasc Interv,2011

5. Cilostazol: Potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding;Goto;Atheroscler Suppl,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis;International Journal of Molecular Sciences;2024-02-23

2. Update on Cilostazol: A Critical Review of Its Antithrombotic and Cardiovascular Actions and Its Clinical Applications;The Journal of Clinical Pharmacology;2021-11-25

3. Current state-of-the-art antiplatelet and anticoagulation therapy in diabetic patients with coronary artery disease;Future Cardiology;2021-05

4. Cilostazol: a Review of Basic Mechanisms and Clinical Uses;Cardiovascular Drugs and Therapy;2021-04-16

5. Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus;Circulation;2020-12